These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34326610)

  • 1. Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.
    Higuera-de la Tijera F; Servín-Caamaño A; Servín-Abad L
    World J Gastroenterol; 2021 Jul; 27(26):4004-4017. PubMed ID: 34326610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.
    Gonzalez SA; Keeffe EB
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):225-50. PubMed ID: 21196168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Coronavirus Disease 2019 Pandemic on Viral Hepatitis Elimination: What Is the Price?
    Sowah L; Chiou C
    AIDS Res Hum Retroviruses; 2021 Aug; 37(8):585-588. PubMed ID: 33913731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
    Stournaras E; Neokosmidis G; Stogiannou D; Protopapas A; Tziomalos K
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1277-1282. PubMed ID: 30179906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and future management of viral hepatitis.
    González Grande R; Santaella Leiva I; López Ortega S; Jiménez Pérez M
    World J Gastroenterol; 2021 Dec; 27(47):8081-8102. PubMed ID: 35068856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical diagnosis of viral hepatitis: Current status and future strategies.
    Shivangi ; Mishra MK; Gupta S; Razdan K; Sudan S; Sehgal S
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116151. PubMed ID: 38184983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis in the elderly.
    Carrion AF; Martin P
    Am J Gastroenterol; 2012 May; 107(5):691-7. PubMed ID: 22290404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral hepatitis B und C].
    Reiser M
    Med Klin (Munich); 2009 May; 104(5):356-62. PubMed ID: 19444416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global elimination of viral hepatitis and hepatocellular carcinoma: opportunities and challenges.
    Chen CJ
    Gut; 2018 Apr; 67(4):595-598. PubMed ID: 29367206
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B virus and hepatitis C virus dual infection.
    Caccamo G; Saffioti F; Raimondo G
    World J Gastroenterol; 2014 Oct; 20(40):14559-67. PubMed ID: 25356020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in diagnosis and treatment of viral hepatitis in children].
    Chang YN; Xu HM
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):16-20. PubMed ID: 33541019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and strategies for viral hepatitis control in Korea.
    Sinn DH; Cho EJ; Kim JH; Kim DY; Kim YJ; Choi MS
    Clin Mol Hepatol; 2017 Sep; 23(3):189-195. PubMed ID: 28942620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
    Hatzakis A; Van Damme P; Alcorn K; Gore C; Benazzouz M; Berkane S; Buti M; Carballo M; Cortes Martins H; Deuffic-Burban S; Dominguez A; Donoghoe M; Elzouki AN; Ben-Alaya Bouafif N; Esmat G; Esteban R; Fabri M; Fenton K; Goldberg D; Goulis I; Hadjichristodoulou C; Hatzigeorgiou T; Hamouda O; Hasurdjiev S; Hughes S; Kautz A; Malik M; Manolakopoulos S; Matičič M; Papatheodoridis G; Peck R; Peterle A; Potamitis G; Prati D; Roudot-Thoraval F; Reic T; Sharara A; Shennak M; Shiha G; Shouval D; Sočan M; Thomas H; Thursz M; Tosti M; Trépo C; Vince A; Vounou E; Wiessing L; Manns M
    J Viral Hepat; 2013 Aug; 20 Suppl 2():1-20. PubMed ID: 23827008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011.
    Christensen PB; Clausen MR; Krarup H; Laursen AL; Schlichting P; Weis N; ;
    Dan Med J; 2012 Jun; 59(6):C4465. PubMed ID: 22677253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis].
    Abdurakhmanov DT
    Ter Arkh; 2013; 85(10):94-7. PubMed ID: 24437226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Changing Global Epidemiology of Hepatocellular Carcinoma.
    Caines A; Selim R; Salgia R
    Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    Howell J; Pedrana A; Cowie BC; Doyle J; Getahun A; Ward J; Gane E; Cunningham C; Wallace J; Lee A; Malani J; Thompson A; Hellard ME
    J Gastroenterol Hepatol; 2019 Jan; 34(1):40-48. PubMed ID: 30151932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease.
    Khoo T; Lam D; Olynyk JK
    World J Gastroenterol; 2021 Aug; 27(29):4831-4845. PubMed ID: 34447229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.